MedPath

Ivermectin

Ivermectin Tablets USP, 3mg (IVERMECTIN)

Approved
Approval ID

ad6539f2-94de-1bc5-e053-2a95a90a4cf2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 20, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ivermectin

PRODUCT DETAILS

NDC Product Code68071-2242
Application NumberANDA204154
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 20, 2022
Generic NameIvermectin

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
IVERMECTINActive
Quantity: 3 mg in 1 1
Code: 8883YP2R6D
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ivermectin - FDA Drug Approval Details